European Pharmaceutical Review

JANUARY 30, 2023

In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs.

Diabetes 73

Diabetes Generic Medicine 73

Quality Matters

JUNE 12, 2023

Complex generics: The need and challenges Generic medicines have benefited millions of Americans and saved trillions of dollars. Accounting for approximately 90% of prescriptions filled in the United States , generic medicines are essential to increasing patient access to important drug therapies.

Generic Medicine 52

Generic Medicine Dosage Prescription Filling Diabetes 52

European Pharmaceutical Review

JULY 25, 2023

percent during the forecast period from 2023 to 2032 is predicted. The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. A compound annual growth rate (CAGR) growth of 5.9

Compounding 77

Compounding Generic Medicine Drug Development Diabetes 77

Express Pharma

JULY 3, 2023

By empowering process development scientists to generate process quality attribute (PQA) data themselves, we enable them to make decisions about which molecules to advance into pre-clinical development more rapidly. resin consumption), and effectively monitor and manage product quality. How poised are you to leverage them?

Biosimilars 83

Biosimilars Drug Development Generic Medicine Diabetes 83

Express Pharma

SEPTEMBER 11, 2023

This move unburdened the private pharma companies allowing them to concentrate and strengthen their base, and they succeeded in gaining a national as well as international market presence as “global generic medicine manufacturers.” Annually, about 2,827 brands with a total value of Rs. 3,810 crores were introduced.

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69